tiprankstipranks
Advertisement
Advertisement

AU:NUZ Stock Latest News

Neurizon issues shares for investor relations as it advances ALS-focused pipeline
Company AnnouncementsNeurizon issues shares for investor relations as it advances ALS-focused pipeline
12d ago
Neurizon Therapeutics Seeks ASX Quotation for 750,000 New Shares
PremiumCompany Announcements
Neurizon Therapeutics Seeks ASX Quotation for 750,000 New Shares
12d ago
Neurizon preclinical data show NUZ-001 boosts dual protein-clearance pathways in ALS models
PremiumCompany Announcements
Neurizon preclinical data show NUZ-001 boosts dual protein-clearance pathways in ALS models
13d ago
Neurizon Director Increases Stake Through $150,000 Share Placement
PremiumCompany Announcements
Neurizon Director Increases Stake Through $150,000 Share Placement
19d ago
Neurizon Sets April 2026 Expiry for NUZOA Listed Options
PremiumCompany Announcements
Neurizon Sets April 2026 Expiry for NUZOA Listed Options
25d ago
Neurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar
PremiumCompany AnnouncementsNeurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar
25d ago
Neurizon Issues Director Shares, Affirms Compliance and Transparency
Premium
Company Announcements
Neurizon Issues Director Shares, Affirms Compliance and Transparency
26d ago
Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
Premium
Company Announcements
Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
26d ago
Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor
PremiumCompany Announcements
Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor
29d ago
Neurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026
PremiumCompany Announcements
Neurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026
1M ago
Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang
PremiumCompany Announcements
Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang
1M ago
Neurizon Draws First $5m Tranche to Advance ALS Drug Trial
PremiumCompany Announcements
Neurizon Draws First $5m Tranche to Advance ALS Drug Trial
2M ago
Neurizon Taps A$5m in Convertible Note Funding From Obsidian
PremiumCompany AnnouncementsNeurizon Taps A$5m in Convertible Note Funding From Obsidian
2M ago
Neurizon issues 10m shares under convertible note, affirms compliance and disclosure
Premium
Company Announcements
Neurizon issues 10m shares under convertible note, affirms compliance and disclosure
2M ago
Neurizon Begins Pivotal NUZ-001 Dosing in HEALEY ALS Platform Trial
Premium
Company Announcements
Neurizon Begins Pivotal NUZ-001 Dosing in HEALEY ALS Platform Trial
2M ago
Neurizon Narrows Half-Year Loss as Other Income Jumps and Net Assets Strengthen
PremiumCompany Announcements
Neurizon Narrows Half-Year Loss as Other Income Jumps and Net Assets Strengthen
2M ago
Neurizon Publishes General Meeting Results and Enhances Investor Engagement
PremiumCompany Announcements
Neurizon Publishes General Meeting Results and Enhances Investor Engagement
2M ago
Neurizon Therapeutics Issues Heavily Qualified General Meeting Presentation
PremiumCompany Announcements
Neurizon Therapeutics Issues Heavily Qualified General Meeting Presentation
2M ago
Neurizon Therapeutics Director Marcus Hughes Increases Shareholding
PremiumCompany Announcements
Neurizon Therapeutics Director Marcus Hughes Increases Shareholding
2M ago
Neurizon Secures FDA Green Light and Full Funding for Late-Stage NUZ-001 ALS Trial
PremiumCompany AnnouncementsNeurizon Secures FDA Green Light and Full Funding for Late-Stage NUZ-001 ALS Trial
2M ago
Neurizon Secures A$6m R&D Tax Rebate to Fund HEALEY ALS Trial
Premium
Company Announcements
Neurizon Secures A$6m R&D Tax Rebate to Fund HEALEY ALS Trial
2M ago
Neurizon Therapeutics Seeks ASX Quotation for 73.5 Million New Shares
Premium
Company Announcements
Neurizon Therapeutics Seeks ASX Quotation for 73.5 Million New Shares
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >